Data Required: IDUs in Manipur - IDU (Intravenous Drug Use) - |
Hanjabam Shukhdeba * |
"Shukhdeba Shrama" Subject : IDUs in Manipur India Dear Sir Greeting from India I have come across your mail from the SEA-AIDS about the information seeking for the IDUs. But India is not mention anywhere. Why is it so. Is it because you have the material or is it bacuse India does not have any IDUs case. I will share you about the case of North East India, which is one of the highest concentration of HIV in India. The mode of transmission is through the IDUs. It is very close to the Golden Traingle (Thailand, Burma or Myanmar, Laos) which is the highest producer in the world as you must have been reported. Manipur share around 350 kilometer with Myanmar and beome a route for drug smuggling. Now there are women drug users also. The goverment are focusing on the IDUs programme. This is the case of one state. There are eight state in Northeast India. IF you miss you this crucial data. You report will be imcomplete in this part of the country. pLease include it With regards On 2/12/08, SEA-AIDS Action: Request for data on IDU and HIV prevalence Benjamin Phillips, Australia **************************************** Reference Group to the UN on HIV and IDU We are looking for data from around the world on the number of injecting drug users and HIV prevalence among IDUs. Do you have data from your country? The Reference Group to the United Nations on HIV and injecting drug useadvises UNODC, UNAIDS and WHO on injecting drug use and on effective approaches to HIV prevention and care for IDUs to help guide strategies for scaling up these activities. See www.idurefgroup.unsw.edu.au for more information about the work of the Reference Group, the international experts who currently make up the group and the Secretariat which is currently based at the National Drug and Alcohol Centre in Australia. One of our major activities is to report on the global extent of IDU and HIV. We are in the process of updating estimates for every country around the world on: 1. The number of people who inject drugs in each country 2. The prevalence of HIV among these injecting drug users Many of you may be familiar with the estimates that were released several years ago by the previous Reference Group. Producing these estimates is difficult because in many countries there are no data measuring the extent of injecting drug use or HIV among injecting drug users. In other countries data may exist, but are not widely available. So far we have conducted a very large search of the peer-reviewed literature and have tried to gather as much greyliterature (such as NGO and government reports) as possible. However we know that there will be some material that our search would have missed. Below is a list of countries that we do not currently have sufficient data on. This lack of data means we will be unable to make direct estimates on the size of the IDU population or the prevalence of HIV among IDUs for these countries. Do you have any information on these countries that may be of use to us? Any assistance you are able to provide will be acknowledged in the reports of the Reference Group. We have only a limited amount of time in which to complete this work. Because of this we will only be able consider material that is sent to us before Friday 15 February 2008 More data is needed for the following countries: Eastern Europe and Central Asia: Bosnia and Herzegovina, Georgia, Lithuania South Asia: Bhutan, Maldives, Sri Lanka East and South East Asia: Brunei Darussalam, Democratic People's Republic of Korea, Japan, Lao People's Democratic Republic, Mongolia, Republic of Korea, Singapore, The Taiwan Provence of China, Timor Leste Caribbean: Antigua and Barbuda, Bahamas, Barbados, Cuba, Dominica, Dominican Republic, Grenada, Haiti, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent & Grenadines, Trinidad and Tobago South America: Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Guyana, Honduras, Nicaragua, Panama, Paraguay, Peru, Suriname, Uruguay, Venezuela Oceania and the Pacific: American Samoa, Federated States of Micronesia, Fiji, French Polynesia, Guam, Kiribati, Marshall Islands, Nauru, New Caledonia, Palau, Papua New Guinea, Samoa, Solomon Islands, Tonga, Tuvalu, Vanuatu Western Europe: Albania, Andorra, Belgium, Iceland, Italy, Finland, France, Liechtenstein, Monaco, Montenegro, San Marino, Serbia, Spain, Switzerland, The Former Yugoslav Republic of Macedonia Middle East and North Africa: Algeria, Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Occupied Palestinian Territories, Oman, Qatar, Saudi Arabia, Sudan, Syrian Arab Republic, Tunisia, Turkey, United Arab Emirates, Yemen Sub-Saharan Africa: Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Côte d'Ivoire, Democratic Republic of the Congo, Djibouti, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mozambique, Namibia, Niger, Nigeria, Republic of the Congo, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, Swaziland, Togo, Uganda, Zambia, Zimbabwe If you have any information you can share with us or you have any further questions please send an email to: [email protected] Benjamin Phillips Research Officer, Secretariat of the Reference Group to the UN on HIV and IDU Email: [email protected] * This information was furnished by Hanjabam Shukhdeba (Integrated MPhil-PHD Scholar, Centre for Research Methodoogy , Tata Institute of Social Sciences ). The submitter can be reached at shukhdeba(dot)sharma(at)tiss(dot)edu . This announcement was posted on February 20th, 2008 . |
* Comments posted by users in this discussion thread and other parts of this site are opinions of the individuals posting them (whose user ID is displayed alongside) and not the views of e-pao.net. We strongly recommend that users exercise responsibility, sensitivity and caution over language while writing your opinions which will be seen and read by other users. Please read a complete Guideline on using comments on this website.